Zogenix Inc (ZGNX.W)

ZGNX.W on CBOE When Trading NASDAQ Global Select Market

2.79USD
17 Apr 2014
Price Change (% chg)

$0.07 (+2.57%)
Prev Close
$2.72
Open
$2.79
Day's High
$2.80
Day's Low
$2.79
Volume
500
Avg. Vol
3,874
52-wk High
$5.14
52-wk Low
$1.27

ZGNX.W

Chart for ZGNX.W

About

Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company’s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled,... (more)

Overall

Beta: 2.13
Market Cap (Mil.): $393.50
Shares Outstanding (Mil.): 139.54
Dividend: --
Yield (%): --

Financials

  ZGNX.W Industry Sector
P/E (TTM): -- 25.47 33.14
EPS (TTM): -0.71 -- --
ROI: -158.92 -2.90 18.95
ROE: -491.54 -12.19 19.71
Search Stocks

U.S. court reverses Massachusetts ban on Zogenix pain drug

- A U.S. District Court judge on Tuesday stopped Massachusetts from implementing a ban on the sale of Zogenix Inc's prescription painkiller Zohydro, saying federal law superseded the state's action.

15 Apr 2014

UPDATE 2-U.S. court reverses Massachusetts ban on Zogenix pain drug

(Adds background, information from court ruling and company, share activity, in paragraphs 2, 7 and 9)

15 Apr 2014

U.S. Federal court stays Massachusetts ban of Zogenix's painkiller

- A U.S. federal court granted Zogenix Inc a preliminary injunction against a ban blocking the sale of its controversial opioid painkiller, Zohydro, in Massachusetts, citing public interest.

15 Apr 2014

U.S. Federal court stays Massachusetts ban of Zogenix's painkiller

April 15 - A U.S. federal court granted Zogenix Inc a preliminary injunction against a ban blocking the sale of its controversial opioid painkiller, Zohydro, in Massachusetts, citing public interest.

15 Apr 2014

Zogenix files lawsuit against Massachusetts over painkiller ban

- Zogenix Inc said it sought a restraining order against an order by Massachusetts officials blocking sales of its FDA-approved painkiller, Zohydro.

07 Apr 2014

Zogenix files lawsuit against Massachusetts over painkiller ban

April 8 - Zogenix Inc said it sought a restraining order against an order by Massachusetts officials blocking sales of its FDA-approved painkiller, Zohydro.

07 Apr 2014

Massachusetts bans sale of FDA-approved Zogenix painkiller

WASHINGTON - Officials in Massachusetts have blocked sales of Zogenix's controversial but U.S.-approved painkiller Zohydro, prompting the drugmaker to criticize what it called an "unprecedented action."

28 Mar 2014

UPDATE 1-Massachusetts bans sale of FDA-approved Zogenix painkiller

WASHINGTON, March 28 - Officials in Massachusetts have blocked sales of Zogenix's controversial but U.S.-approved painkiller Zohydro, prompting the drugmaker to criticize what it called an "unprecedented action."

28 Mar 2014

CORRECTED-Massachusetts bans sale of FDA-approved Zogenix painkiller

(Corrects analyst's name in 12th paragraph to Smith from Cox)

28 Mar 2014

FDA chief defends new pain drug despite worries about abuse

WASHINGTON - The head of the Food and Drug Administration on Thursday defended the agency's approval of Zohydro, a powerful prescription opioid made by Zogenix Inc, saying it offers a "unique" option to treat pain despite concerns about potential abuse.

13 Mar 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks